These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33274381)

  • 21. Application of multivariate statistics to the Steroidal Module of the Athlete Biological Passport: A proof of concept study.
    Alladio E; Caruso R; Gerace E; Amante E; Salomone A; Vincenti M
    Anal Chim Acta; 2016 May; 922():19-29. PubMed ID: 27154828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of synthetic isoflavones on selected urinary steroid biomarkers: Relevance to doping control.
    Iannone M; Alberti F; Braganò MC; de la Torre X; Molaioni F; Botrè F
    Steroids; 2021 Oct; 174():108900. PubMed ID: 34391799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of analytical approaches for the detection of oral testosterone undecanoate administration in men.
    Langer T; Nicoli R; Schweizer-Grundisch C; Grabherr S; Kuuranne T; Musenga A
    Drug Test Anal; 2024 Oct; 16(10):1155-1166. PubMed ID: 38205661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.
    Di Luigi L; Sgrò P; Romanelli F; Mazzarino M; Donati F; Braganò MC; Bianchini S; Fierro V; Casasco M; Botrè F; Lenzi A
    J Endocrinol Invest; 2009 May; 32(5):445-53. PubMed ID: 19461217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of the urinary and blood steroid profiles in healthy and physically active women with and without oral contraception.
    Moreillon B; Salamin O; Krumm B; Iannella L; Molaioni F; Kuuranne T; Nicoli R; Saugy JJ; Botrè F; Faiss R
    Drug Test Anal; 2023 Mar; 15(3):324-333. PubMed ID: 36414566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the administration of miconazole by different routes on the biomarkers of the "steroidal module" of the Athlete Biological Passport.
    Mazzarino M; Comunità F; de la Torre X; Molaioni F; Botrè F
    Drug Test Anal; 2021 Oct; 13(10):1712-1726. PubMed ID: 34212529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of thyroid hormones administration on urinary endogenous steroid profile of the athlete biological passport.
    Martínez Brito D; de la Torre X; Botrè F
    Drug Test Anal; 2023; 15(11-12):1361-1370. PubMed ID: 37339884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
    Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
    Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate interpretation of the urinary steroid profile and training-induced modifications. The case study of a Marathon runner.
    Amante E; Pruner S; Alladio E; Salomone A; Vincenti M; Bro R
    Drug Test Anal; 2019 Oct; 11(10):1556-1565. PubMed ID: 31307117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
    Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
    J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine.
    Fabregat A; Marcos J; Segura J; Ventura R; Pozo OJ
    Drug Test Anal; 2016 Jan; 8(1):110-9. PubMed ID: 25917157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled administration of dehydrochloromethyltestosterone in humans: Urinary excretion and long-term detection of metabolites for anti-doping purpose.
    Loke S; de la Torre X; Iannone M; La Piana G; Schlörer N; Botrè F; Bureik M; Parr MK
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105978. PubMed ID: 34418529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of testosterone microdosing in healthy females.
    Savkovic S; Ly LP; Desai R; Howa J; Nair V; Eichner D; Handelsman DJ
    Drug Test Anal; 2022 Apr; 14(4):653-666. PubMed ID: 34811948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of urinary excretion of androgens conjugated to cysteine in human pregnancy by mass spectrometry.
    Fabregat A; Marcos J; Garrostas L; Segura J; Pozo OJ; Ventura R
    J Steroid Biochem Mol Biol; 2014 Jan; 139():192-200. PubMed ID: 23410595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary steroid profile in relation to the menstrual cycle.
    Schulze J; Suominen T; Bergström H; Ericsson M; Björkhem Bergman L; Ekström L
    Drug Test Anal; 2021 Mar; 13(3):550-557. PubMed ID: 33142032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
    Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of urinary metabolites of arimistane in humans by gas chromatography coupled to high-accuracy mass spectrometry for antidoping analyses.
    Martinez Brito D; de la Torre X; Botrè F
    Rapid Commun Mass Spectrom; 2019 Dec; 33(24):1894-1905. PubMed ID: 31295379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport.
    Becchi M; Aguilera R; Farizon Y; Flament MM; Casabianca H; James P
    Rapid Commun Mass Spectrom; 1994 Apr; 8(4):304-8. PubMed ID: 8199357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of longitudinal steroid profiling with the ADAMS adaptive model for detection of transdermal, intramuscular, and subcutaneous testosterone administration.
    Nair VS; Husk J; Miller GD; van Eenoo P; Crouch A; Eichner D
    Drug Test Anal; 2020 Oct; 12(10):1419-1431. PubMed ID: 32578357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroidomics for highlighting novel serum biomarkers of testosterone doping.
    Ponzetto F; Boccard J; Nicoli R; Kuuranne T; Saugy M; Rudaz S
    Bioanalysis; 2019 Jun; 11(12):1171-1187. PubMed ID: 31179715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.